Doherty Institute research prompts doctors to switch treatments for golden staph
Groundbreaking research led by the Doherty Institute has found that traditional antibiotic flucloxacillin is less effective and more toxic for treating golden staph infections. The study revealed that alternatives cefazolin and benzylpenicillin significantly improved survival rates, prompting doctors like Professor Steven Tong to change their treatment protocols. Golden staph infections contribute to over 1 million deaths annually worldwide.
Summary by OZbrief · Brisbane Times
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.



